Canagliflozin Reduces HbA1C in Patients with Stage 3 CKD, with the Change Greater in Patients with Higher eGFR

Article Information

Published By 
Print ISSN 
Online ISSN 

Author Information

  1. Wayne Kuznar
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015100
Jul 2015111
Aug 2015100
Sep 2015100
Oct 2015632
Total1643

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.